SEARCH

REUTERS NEXT- SERUM INSTITUTE CEO EXPECTS TO COMPLETE PHASE III SAFETY, IMMUNOGENICITY TRIAL IN INDIA IN A MONTH OR TWO

14 Jan 2021 / 17:18 H.

    REUTERS NEXT- SERUM INSTITUTE CEO EXPECTS TO COMPLETE PHASE III SAFETY, IMMUNOGENICITY TRIAL IN INDIA IN A MONTH OR TWO

    email blast